ISL
CEMI

Ingalls & Snyder LLC’s Chembio diagnostics, Inc. CEMI Stock Holding History

Ingalls & Snyder LLC’s Portfolio CEMI Stock Details CEMI Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q2 		– Sell
-266,473
Closed -$1.36M – 444
2020
Q1 		$1.36M Sell
266,473
-42,771
-14% -$173K 0.09% 154
2019
Q4 		$1.41M Buy
309,244
+6,000
+2% +$29.2K 0.08% 165
2019
Q3 		$1.86M Buy
303,244
+5,167
+2% +$30.8K 0.09% 159
2019
Q2 		$1.81M Sell
298,077
-1,500
-0.5% -$10.1K 0.09% 165
2019
Q1 		$1.66M Sell
299,577
-18,062
-6% -$117K 0.08% 173
2018
Q4 		$1.8M Buy
317,639
+13,271
+4% +$97.8K 0.1% 159
2018
Q3 		$3.2M Buy
+304,368
New +$3.27M 0.14% 125

Other funds holding CEMI

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
RA
Royce & Associates New York $10.1B AUM 42.88% 1-Year Est. Return
KCM
Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return
SBH
Segall Bryant & Hamill Chicago, Illinois $6.98B AUM 34.78% 1-Year Est. Return
HA
Heartland Advisors Milwaukee, Wisconsin $1.96B AUM 28.26% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $1.6B AUM 121.58% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PM
Penbrook Management New York $132M AUM 29.91% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return